Sigal Pressman

Haifa, HA 31096, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Drug-Tolerant, Chemiluminescent Lateral Flow Immunoassay Platform for the Determination of Neutralizing Anti-Drug Antibodies.

Drug-Tolerant, Chemiluminescent Lateral Flow Immunoassay Platform for the Determination of Neutralizing Anti-Drug Antibodies.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: May 19, 2025

Inflammation and bacteriophages affect DNA inversion states and functionality of the gut microbiota.

Inflammation and bacteriophages affect DNA inversion states and functionality of the gut microbiota.

Journal: Cell host & microbe

Published: April 01, 2023

A personalized network framework reveals predictive axis of anti-TNF response across diseases.

A personalized network framework reveals predictive axis of anti-TNF response across diseases.

Journal: Cell reports. Medicine

Published: February 21, 2023

Differential Serum-intestinal Dynamics of Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.

Differential Serum-intestinal Dynamics of Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.

Journal: Journal of Crohn's & colitis

Published: December 01, 2021

Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN.

Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN.

Journal: Gut

Published: May 16, 2021

Infliximab-Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies.

Infliximab-Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies.

Journal: Gastroenterology

Published: April 18, 2019

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD.

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD.

Journal: Gut

Published: October 20, 2017

Anti-infliximab Antibodies with Neutralizing Capacity in Patients with Inflammatory Bowel Disease: Distinct Clinical Implications Revealed by a Novel Assay.

Anti-infliximab Antibodies with Neutralizing Capacity in Patients with Inflammatory Bowel Disease: Distinct Clinical Implications Revealed by a Novel Assay.

Journal: Inflammatory bowel diseases

Published: April 28, 2016

Showing 1-8 of 8

Last Updated: 09/26/2026